Evidence map›Paper›PMID 40335530›Full record

ArticleScientific reports2025

A Radiomic-based model to predict the depth of myometrial invasion in endometrial cancer on ultrasound images.

Francesca Arezzo, Annarita Fanizzi, Rosanna Mancari, Emiliano Cocco, Samantha Bove, Maria Colomba Comes, Mariangela Gianciotta, Giorgia Lanza, Salvatore Lopez, Gerardo Cazzato and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Francesca Arezzo *Clinicalized Gynecological Oncology Unit , IRCCS Istituto Tumori 'Giovanni Paolo II' , Viale Orazio Flacco 65, 70124, Bari, Italy.
Annarita Fanizzi *Biostatistics and Bioinformatics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, Bari, 70124, Italy.
Rosanna MancariGynecologic Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, 00144, Italy.
Emiliano CoccoSylvester Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.
Samantha BoveBiostatistics and Bioinformatics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, Bari, 70124, Italy. s.bove@oncologico.bari.it.
Maria Colomba ComesBiostatistics and Bioinformatics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, Bari, 70124, Italy. m.c.comes@oncologico.bari.it.
Mariangela GianciottaObstetrics and Gynecology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Giorgia LanzaObstetrics and Gynecology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Salvatore LopezClinicalized Gynecological Oncology Unit , IRCCS Istituto Tumori 'Giovanni Paolo II' , Viale Orazio Flacco 65, 70124, Bari, Italy.
Gerardo CazzatoDepartment of Emergency and Organ Transplantation, Pathology Section, University of Bari "Aldo Moro", Bari, Italy.
Erica SilvestrisClinicalized Gynecological Oncology Unit , IRCCS Istituto Tumori 'Giovanni Paolo II' , Viale Orazio Flacco 65, 70124, Bari, Italy.
Elsa VitaleBiostatistics and Bioinformatics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, Bari, 70124, Italy.
Enrico VizzaGynecologic Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, 00144, Italy.
Gennaro CormioClinicalized Gynecological Oncology Unit , IRCCS Istituto Tumori 'Giovanni Paolo II' , Viale Orazio Flacco 65, 70124, Bari, Italy.
Raffaella Massafra *Biostatistics and Bioinformatics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, Bari, 70124, Italy.
Vera Loizzi *Clinicalized Gynecological Oncology Unit , IRCCS Istituto Tumori 'Giovanni Paolo II' , Viale Orazio Flacco 65, 70124, Bari, Italy.

Funding

Ministry of Health 5 per 1000
6 · The paper itself

Abstract

In Europe, endometrial carcinoma was found to be the fourth most common tumor in the female population in 2022. The depth of myometrial invasion is a well-established and crucial prognostic risk factor in endometrial cancer patients and is important for choosing the most appropriate management for the patient. However, while the preoperative assessment of tumor invasion carried out using radiological imaging is very important, it is a subjective examination and its accuracy is based on the experience of the operator. In this scenario we proposed a radiomic-based model to predict myometrial invasion for ultrasound images. We collected clinical data and qualitative ultrasound indicators of 77 consecutive patients affected by endometrial carcinoma. After a pre-processing phase of ultrasound images, a pre-trained Inception-V3 convolutional neural network (CNN) was used as features extractor. Then, a binary classification model and a multiclass model were trained, after a double step of feature selection; the first selection stage performed feature filtering based on a nonparametric test, the second stage selected features by evaluating not only the relationship with the outcome of interest, but also the relationship with other predictive features. For the multiclass prediction model, a cascade approach has been developed. The two proposed models were validated in 100 ten-fold cross-validation rounds. In addition, to assess the effect of the potential added value of using this tool in clinical practice, we compared the operator's performance with and without the developed automated support. The binary and multiclass model reached optimal classification performances with a mean AUC value equals to 90.76 (88.63-92.89 IC95%). When the operator was assisted by the radiomic-based decision-making system increased by 10% points in terms of precision. The multiclass model showed the per-classes recall were 93.33%, 71.88% and 90.00%, for focal infiltration, infiltration less than 50%, and infiltration greater than 50% class, respectively. The performances of the operator when assisted by the radiomic-based decision-making system were statistically superior both in terms of overall accuracy and per-class recall of intermediate class (rising to 82.82% and 71.88% compared to 71.88% and 56.25%, respectively). The proposed models have the potential to standardize examinations that rely on subjective evaluations, such as ultrasound. They can represent a valid support tool for the clinicians for an accurate estimate of the deep myometrial infiltration already in the diagnosis phase with an easily accessible, low-cost examination that causes no discomfort for the patient such as ultrasound.

Indexed as

Endometrial NeoplasmsMyometriumAdultAgedFemaleHumansMiddle AgedNeoplasm InvasivenessNeural Networks, ComputerRadiomicsUltrasonographyDepth of myometrial invasionEndometrial CancerImaging in gynecological diseaseRadiomic modelUltrasound

Identifiers

PMID40335530
PMCPMC12058973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.